medigraphic.com
ISSN 2007-6517 (Print)

2013, Number 1

<< Back Next >>

Rev Latinoam Cir 2013; 3 (1)

Deep vein thrombosis as the initial manifestation of a pure endodermal sinus tumor: A case report

Ramírez GLR, Leonher RKL, Jiménez GJA, López ZJ, Medina HE,Tello BIM

Language: Spanish
References: 14
Page: 51-53
PDF size: 227.54 Kb.


ABSTRACT

Background: The clinical thromboembolism occurs in 11% of patients with cancer and is the second leading cause of death in patients with malignancy given that the tumor expresses procoagulant activity can directly induce the formation of thrombin.
Case report: We report the case of a male patient aged 29 with deep venous thrombosis of the right lower limb and migratory superficial thrombophlebitis as the first manifestation of a pure endodermal sinus tumor.
Conclusion: On many occasions, patients present with thrombosis due to an occult malignancy are diagnosed months after the thrombotic event. Usually not detected neoplasia upon presentation of thrombosis and in the event that the tumor is usually is an adenocarcinoma.


REFERENCES

  1. Goldenberg, N, Kahn, SR, Solymoss, S. Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism. J Clin Oncol. 2003;21:4194.

  2. Maraveyas A, Johnson M. Does clinical method mask significant VTE-related mortality and morbidity in malignant disease? Br J Cancer. 2009;100:1837.

  3. Levine, M. Treatment of thrombotic disorders in cancer patients. Haemostasis. 1997;27(Suppl 1):38.

  4. Sack GH Jr, Levin J, Bell WR. Trousseau’s syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: Clinical, pathophysiologic, and therapeutic features. Medicine (Baltimore). 1977;56:1.

  5. Donati, MB. Cancer and thrombosis: From phlegmasia alba dolens to transgenic mice. Thromb Haemost. 1995;74:278.

  6. Sproul, EE. Carcinoma and venous thrombosis: The frequency of association of carcinoma in the body or tail of the pancreas with multiple venous thrombosis. Am J Cancer. 1938;34:566.

  7. Rickles FR, Edwards RL. Activation of blood coagulation in cancer: Trousseau’s syndrome revisited. Blood 1983;62:14.

  8. Levitan N, Dowlati A, Remick SC et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore). 1999;78:285.

  9. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343:1846.

  10. Mandala M, Reni M, Cascinu S et al. Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients. Ann Oncol. 2007;18:1660.

  11. Mandala M, Moro C, Labianca R, Ferretti G. Erlotinib in pancreatic cancer patients: do we need more information from the NCIC CTG trial? J Clin Oncol. 2007;25:4320.

  12. Hedderich, GS, O’Connor, RJ, Reid, EC, Mulder, DS. Caval tumor thrombus complicating renal cell carcinoma. A surgical challenge. Surgery. 1987;102:614.

  13. Siegelman, ES, Needleman, L. Venous thrombosis and cancer (letter). N Engl J Med. 1992;328:885.

  14. Bell, WR, Starksen, NF, Tong, S et al. Trousseau’s syndrome: Devastating coagulopathy in the absence of heparin. Am J Med. 1985;79:423.




2020     |     www.medigraphic.com